Inhibikase Therapeutics IKT
NASDAQ IKT
$1.63 -0.03 (-1.81%)
At close: Oct 22, 2026 · 4:00 PM EDT

Inhibikase Therapeutics (IKT) Change in Other Operating Liabilities (2020 - 2025)

Updated

Analysis

Inhibikase Therapeutics (IKT) Change in Other Operating Liabilities (2020 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Liabilities Change (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn -
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 2.69 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn -
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn -
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn -
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn -
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn -32.00 Mn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -112.00 Mn
10 Inhibikase Therapeutics 284.55 Mn -300.92 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 37,944.00
Jun 30, 2025 36,828.00
Mar 31, 2025 35,745.00
Dec 31, 2024 34,693.00
Sep 30, 2024 32,620.00
Jun 30, 2024 31,660.00
Mar 31, 2024 30,729.00
Dec 31, 2023 29,824.00
Sep 30, 2023 27,894.00
Jun 30, 2023 27,074.00
Mar 31, 2023 26,276.00
Dec 31, 2022 -13,824.00
Sep 30, 2022 -1.00
Jun 30, 2022 23,684.00
Sep 30, 2021 -142,619.00
Jun 30, 2021 -1.11 Mn
Mar 31, 2021 -1.07 Mn
Dec 31, 2020 367,187.00
Sep 30, 2020 446,410.00
Jun 30, 2020 40,556.00
API Access

Inhibikase Therapeutics Change in Other Operating Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-other-operating-liabilities&ticker=IKT&period=max&api_key=YOUR_API_KEY